Simpozionul de Studii Clinice Synevo 2016

Simpozionul de Studii Clinice Synevo 2016


Dragi colegi si prieteni,

Am placerea de a va anunta ca anul acesta se va desfasura a 8-a editie a Simpozionului de Studii Clinice, eveniment organizat in Bucuresti, Romania.

Va invitam sa ne fiti alaturi la acest eveniment dedicat profesionistilor din domeniul studiilor clinice, sponsori pharma, companii Biotech, reprezentanti ai CRO-urilor, investigatori (clinicieni si medici generalisti, specialisti de laborator, chimisti, biologi, biochimisti).

Veti avea ocazia sa ascultati prezentarile unor foarte cunoscuti lectori, lideri de opinie in domeniul lor, intr-o atmosfera relaxanta unde veti putea cultivata noi relatii si relationa cu colegii.

Evenimentul este creditat cu credite EMC.

Numarul participantilor este limitat. Asteptam cu nerabdare sa ne intalnim pe 25 Noiembrie 2016, la Hotelul Intercontinental, Bucuresti, Romania.

Cristina Florescu Moraid, Md, Msc, EuSpLM
Regional Director Romania, Moldova, Bulgaria and Serbia Synevo Central Lab

4

Sectiuni

15

Lectori

480

Participanti

13

Tari participante

8

ani de traditie

AGENDA

  • 08:00-09:00Inregistrare participanti

  • 09:00-09:15Deschiderea oficiala

    Cristina Florescu Moraid, MD, MSc, EUSpLM - Synevo Central Lab Regional Country Director Romania, Republic of Moldova, Bulgaria & Serbia
  • 09:15-11:45SECTIUNEA INVESTIGATORULUI

    Moderator Sectiunea Investigatorului:
    Marius Geanta - MD, CEO Centrul pentru Inovatie in Medicia, Romania

    9:15-9:45 AM
    Victoria Arama - Prof., MD, PhD - INBI Matei Bals Bucharest, Romania
    Titlu: “Experienta Institutului National de Boli Infectioase Prof Dr  Matei Bals in studiile clinice cu molecule noi active pe virusurile hepatitice B si C”

    9:45-10:15 AM
    Laurentiu Micu - MD, PhD – Spitalul Fundeni, Bucuresti, Romania
    Titlu: “Studiile clinice in tratamentul infectiei cronice VHC: o poveste de succes"

    10:15-10:45 AM
    Iulia Chiriac - MD, Institutul National de Endocrinologie C.I.Parhon, Bucuresti, Romania
    Title: "BIOMAT-ENDO: Rezultatele preliminare privind 2000 de cazuri decarcinom tiroidian."

    10:45-11:15 AM
    Jack Whelan – Research Advocate USA
    Titlu : "Convergenta studiilor clinice bazate pe biomarkeri si a noilor tehnologii din domeniul IT au schimbat radical industria farma, a CRO-urilor si a laboratorelor centrale. Sunteti pregatiti?”
  • 11:15-11:45Pauza de cafea si discutii libere

  • 11:45-13:00SECTIUNEA LABORATORULUI

    Moderator Sectiunea Laboratorului:

    Michael OellerichMD,PhD- Universitatea “George-August”, Facultatea de Medicina, Gottingen, Germany

    11:45-12:05 AM
    Cristina Florescu Moraid - MD,MSc, EuSpLm - Director Regional, Synevo Central Lab Romania
    Titlu: “Faza pre-analitica a testelor de laborator - o adevarata provocare pentru laboratoare?”

    12:05-12:30 PM
    Dunja Rogic – Prof. Dr., MD, PhD - Institutul Clinic pentru Diagnostic de Laborator - Spitalul Clinic Central, Zagreb, Croatia
    Titlu: „Comentarii interpretative - valoare adaugata in faza post-analitica”

    12:30-13:00 PM
    Michael Oellerich - MD, PhD,- Professor Chemie Clinica in cadrul Facultatii de Medicina George-August Göttingen, Germania
    Titlu: “Medicina de laborator - provocari si oportunitati”
  • 13:00-14:00Pauza de masa

    Hotel Intercontinental
  • 14:00-16:00SECTIUNEA CRO-SPONSOR

    Moderator Sectiunea CRO & SPONSOR
    Julian Platon - MD, PhD - R&D and Medical Affairs Consultant, Switzerland

    14:00-14:30 AM
    Ivan Georgiev MD - Country Manager Quintiles Bulgaria
    Titlu: “România și Bulgaria pe harta studiilor clinice”.

    14:30-15:00 AM
    Eduard PADURARU - Clinical Operations Project Manager Servier Pharma Romania
    Titlu: Operatiunile clinice intre CRO si Sponsor

    15:00-15:30 AM
    Regio Tanaseanu - MD - Director PSI CRO AG Romania
    Titlu: Organizarea unui studiu clinic cu testare microbiologica-studiu de caz

    15:30-16:00 AM
    Julian Platon - MD, PhD - R&D and Medical Affairs Consultant, Switzerland
    Titlu: “Organizarea fazei de start-up in studiile multinationale”
  • 16:00-16:15Pauza de cafea

  • 16:15-18:15SECTIUNEA REGULATORY & VARIA

    Moderator Sectiunea Regulatory & Varia
    Cristina Florescu Moraid - MD,MSc, EuSpLm - Synevo Central Lab Regional Director

    16:15-16:40 AM
    Lina Gudima - MD, PhD - Director Departament Studii Clinice, Agentia Nationala a Medicamentului, Republica Moldova
    Titlu: “Studiile Clinice in Republica Moldova”

    16:40-17:00 AM
    Constantin Mircioiu - MD, PhD - Presedinte al Departamentului Farmaceutic, Academia de Stiinte Medicale, Comitetul National de Bioetica Medicamentelor si Dispozitive Medicale, Romania
    Titlu: “Componentele biofarmaceutice si de biostatistica in studii clinice”

    17:00-17:30 AM
    JANOSI ISTVAN - Assoc. PLANIMETER, HUNGARY
    Titlu: “Raportul de caz in format electronic - solutii tehnice avansate”

    17:30-18:00 AM
    Marius Geanta - MD - CEO Center for Innovation in Medicine, Bucharest
    Titlu: “Regândim sănătatea: medicina personalizată pentru pacienții din România“
  • 18:15-18:20TOMBOLA

  • 18:20-19:00Musical Soiree

    ETNOTHIC
  • 19:00-19:30Inchiderea lucrarilor si acordarea diplomelor


LECTORI

Cristina Florescu-Moraid Dr.

Cristina Florescu-Moraid, MD, MSc, EUSpLM

Synevo Central Lab Country Director Romania, Republic of Moldova, Bulgaria & Serbia


„Cristina Florescu-Moraid este medic si conduce din anul 2005 divizia de operatiuni a companiei Synevo Central Lab din Romania, Republica Moldova, Bulgaria si Serbia. Traseul sau profesional include coordonarea a peste 180 de proiecte dintre care mai multe de 100 de studii clinice.
In 1997 absolva Universitatea de Medicina si Farmacie (UMF) „Carol Davila” din Bucuresti, devenind medic specialist in medicina de laborator in anul 2005 si medic primar in aceeasi specialitate in 2011.
Dintre multiplele cursuri si programe urmate de Cristina, pentru pregatirea sa ca manager se remarca masterul in management si sanatate publica obtinut in 2006 la UMF „Carol Davila” din Bucuresti, cursul postuniversitar de management al studiilor clinice de la Fundatia pentru Dezvoltare in Management Gdansk, Polonia, din anul 2012 si programul postuniversitar de dezvoltare si leadership absolvit in 2014 la Universitatea din Sussex, Marea Britanie.
Vasta sa experienta in industria de laborator si studii clinice depaseste 15 ani, astfel ca este deseori invitata ca lector la evenimente internationale de medicina de laborator si cercetare clinica. In plus, organizeaza cursuri si traininguri dedicate specialistilor din domeniul studiilor clinice.”

Dunja Rogić, Professor PhD

Professor Dunja Rogić, PhD


Prof. Dunja Rogić, PhD, medical biochemistry specialist, graduated in 1986 from School of Pharmacy and Biochemistry, University of Zagreb, in the 1986-1987 period she did postgraduate study at School of Pharmacy and Biochemistry, University of Zagreb, she was in the 1987-1992 employed in Laboratory for Endocrinology, University Hospital Center Zagreb, in 1991 defended her master's thesis, in the 1992-1995 period was a resident in laboratory medicine (in 1995 she passed specialist exam in laboratory medicine), was Head of General Clinical Chemistry Laboratory, University Hospital Center Zagreb in the 1995-2002 period, won her PhD degree, and was awarded MBA degree - Leadership and Management in Health Services, Zagreb University School of Medicine and London School of Economics (2001-2003). In 2008 she was elected Assistant Professor at School of Pharmacy and Biochemistry, University of Zagreb, and since 2013 she has been Head of Department of Laboratory Diagnostics, University Hospital Center Zagreb, and Associate Professor at School of Pharmacy and Biochemistry, University of Zagreb.

She has been an invited speaker/participant in many scientific meetings in Croatia and abroad, author and co-author of more than 50 scientific papers. Her fields of interest: evidence-based medicine, POCT, organization & management of clinical laboratory, laboratory parameters of renal diseases. She has been a lecturer and organizer of continuous education courses for physicians and medical biochemists, and editor/co-editor of several textbooks and author of book chapters. She is a full member of EFLM Postanalytical WG. She is actively involved in undergraduate and graduate teaching at School of Pharmacy and Biochemistry, University of Zagreb, and School of Medicine, University of Zagreb; course leader: Evidence-based Laboratory Medicine.

Gudima Lina Dr.

Dr. Gudima Lina


10/2005–17/09/2007

Medical doctor
Municipal Clinical Hospital "Railway" of Moldova, Chishinau (Moldova)
09/2007–06/2012
Medical doctor
Medicines and Medical Devices Agency, Medicines authorisation department, Chishinau (Moldova)
authorisation of medicines
06/2012–Present
Medical doctor
Medicines and Medical Devices Agency, Clinical Trials Research Department, Chishinau (Moldova)
Head of Clinical Trials Research Department
2007–2012
Medical doctor
Medicines and Medical Devices Agency, Chishinau (Moldova)
member of working group within the MMDA for centralized procurement
12/2014–2016
Medical doctor, Pharmacovigilance trainer
Center of Health Policies and Studies of Republic of Moldova, Chisinau (Moldova)
Pharmacovigilance in introduction of new anti TB products
31/03/2012–31/03/2012
Clinical Trials according to GCP
Arensia Exploratory Medicine GmbH, Chishinau (Moldova)
04/10/2012–05/10/2012
master-calss – Quality assurance and control in clinical trials
The State Expert Center of the MoH of Ukraine, Kyiv (Ukraine)
13/10/2012
GCP Training for Investigators
Hoffman la Roche, Chishinau (Moldova)
04/10/2012–05/10/2012
participant of the 4-th scientific and practical conference with international participation „Clinical trials of medicinal products in Ukraine
The National Academy of Medical Sciences of Ukraine, Kyiv (Ukraine)
12/10/2012 “Основы международной регистрации лекарственных средств”
Vialek Ukraine, Chishinau (Moldova)
23/11/2012–24/11/2012 speaker
„Synevo 2012 – Conference for Clinical Trials”presentation „Challenges in conducting clinical trials in
the Republic of Moldova, Bucharest (Romania)
25/06/2013–26/06/2013 Cerificate of completion: Introduction to the Clinical Drug
Development Process: ICH Good Clinical Practice for Clinical Trials
Sites
Quintiles Global Talent, Development and Engagement, Chishinau (Moldova)
23/10/2013–25/10/2013 Training course
Practical GCP Compliance Auditing of Trials and Systems, London (United Kingdom)
16/03/2013 GCP Refresher Training
Arensia Exploratory Medicine, Chishinau (Moldova)
18/04/2013–19/04/2013 6-th Annual CIS and SEE Clinical Trials
Fleming Europe, Zagreb (Croatia)
05/2013 The training of internal auditors and managers in the standards
system in SM SR EN ISO 9001:2011; SM SR EN ISO/CEI
17025:2006 and SM SR EN ISO 19011:2012
National Institute of Standardization and Metrology Moldova, Chishinau (Moldova)
09/09/2013–12/09/2013 speaker
scientific-practical conference MoldMedizin 2013 in the exhibition "Rational use of medicines ",
Chishinau (Moldova)
07/09/2014–09/09/2014 speaker
development project "Strengthening the Moldovan pharmaceutical sector and Medical Devices
Agency for Medicines and" Speaker "Clinical Trials in Moldova" and "Marketing Authorisation
procedure in Moldova", Tartu (Estonia)
18/03/2015 Экспертиза регистрационного досье в формате СТD Модуль 1-3
Vialek, Chishinau (Moldova)
29/02/2016–01/03/2016 Participant work-shop HINARI- health research
MoH, Moldova and WHO, regional office for Europe, Chishinau (Moldova)

JANOSI ISTVAN Assoc. - PLANIMETER, HUNGARY

István Jánosi

PLANIMETER, HUNGARY


István graduated at KLTE, in Debrecen, Hungary as a mathematician in 1990.

He has been working as biostatistician since then. He spent four years at Semmelweis Medical University (Budapest) supporting the academic research conducted by the university teams and individuals.

After the Berlin wall fell a very sparkling life started in Hungary with marketing hundreds of new drugs to a market which required new study results including Hungarian patients. After a short freelancer period István started Planimeter Kft, a full service CRO which still has been managed by him. He designed, evaluated and reported numerous studies covering pre-clinical, Phase I-IV studies and post-marketing surveys during 25 years of his activity. Beyond acting as statistician István also collected rich experiences in Data Management. With his team he implemented an electronic CRF system which currently operates in 8 countries and designed several Patient Registries.

He also works as contract statistician time-by-time. He started with Accovion in 2009 and continued with CSL Behring in 2011, Bayer Healthcare (2013) and Novartis (2015). István has been a member of ISCB (International Society for Clinical Biostasticians) since 1990 and DIA (Drug Information Association) from 2013. Author or co-author of several publications, including a book on Statistics (in Hungarian).

Jack Whelan - Research Advocate USA

Jack Whelan

Research Advocate USA


Jack Whelan is an eight year survivor of a rare, incurable blood cancer moving from a career IT Research Analyst to Research Advocate; he was recently diagnosed with an aggressive form of metastatic prostate cancer for which he is in treatment. Travel with Jack on an intensely personal and often humorous bumpy ride on the road to Personalized Medicine which is still under construction as he participates in seven Clinical trials. Using business communications and research skills coming from his career as a Wall Street Research Analyst and career Sales VP in IT, he now helps bridge the communications gap between life sciences, medical professionals and patients. Jack hopes all appreciate the real value and noble work of life sciences employees and companies involved in cancer research and care. A decided friend to BioPharma and CROs as an engaged, informed e-Patient Opinion Leader (POL) and Advocate he regularly speaks to and for these companies, to open much-needed communications lines with patients, providers and policymakers. He encourages all patients to explore novel targeting agents and immunotherapies many of which are now in Clinical Trials. Using genetic and genomic information to develop new disease-specific targeted therapeutics might be safer and more effective treatment than conventional chemotherapy.

Jack’s a frequent speaker and participant at the best industry and advocacy conferences in the Americas and Europe sharing his engaging, gripping, hopeful and fun story about survival. Jack understands the realities of his blood cancer as he has repeatedly relapsed and has been refractory to most of the therapies received thus far; however his goal is repeated periods of progression free survival during which the promise of science and delivery of successful therapeutics will be achieved. His website is located at Jack-Whelan.com

Other information of potential interest:

In advocacy he’s an active member with AACR, ASCO, DIA, LLS, RDLA, NORD, NIH’s NCTN, ACRES and Transcelerate as Patient Advocate focused on Clinical Trials. He lives in Andover Massachusetts with his wife Jan, has three ‘fabulous’ daughters and sons-in-law and proud grandparents of six grandkids four of whom are twins He’s an associate member of the American Association for Cancer Research (AACR), completed the 2013 and 2014 Scientist-Survivor Programs and Science of Cancer Disparities in Research program, featured cover story of AACR’s Cancer Today Magazine, the AACR Annual (2014) Cancer Progress Report and appears in one of AACR’s national network TV fundraising commercials. He was a speaker at AACR’s 2015 and 2016 Annual Meeting. As a strong proponent of rational funding for biomedical research and to convince Congress to make this a national priority he will participate in his third AACR-led Rally for Medical Research this Sept ’16. Jack has been an event speaker for and is a strong supporter of AACR Foundation. He serves on the editorial board of AACR’s Cancer Today Magazine.

He is also active with the American Society of Clinical Oncology (ASCO), completed the Research Advocacy Network Focus on Research Scholars in conjunction ASCO’s Patient Advocacy Education Programs in 2013, 2015 and 2106. He serves on ASCO’s Patient Advisory Committee advising and promoting ASCO’s CancerLinQ EHR development programs. He is also active with and completed the Drug Information Association (DIA) Patient Advocate Fellowship Program in, has produced educational videos & webcasts for DIA. Jack is a keynote speaker and Co-Chair of the Research Advocacy Council of the Alliance for Clinical Research Excellence and Safety (ACRES) and member of the Patient Advisory Board at Transcelerate, both organizations are strong proponents of improving the Clinical Trials industry.

He’s an active volunteer with the International Waldenstrom’s Macroglobulinemia Foundation (IWMF) a charitable advocacy that provides patient education, support and funds research. He is IWMF’s New England Support Group Leader and a keynote speaker at IWMF’s Annual Educational Patient-Physician Forum.

He's active with Leukemia & Lymphoma Society (LLS) as speaker recruiting for LLS’ Team in Training and Light the Night, a First Connection patient advocate; he’s a speaker at local LLS’ support groups. He received the LLS’ 2014 Quality of Life Award and a 2016 Fight Against Blood Cancer Award. As a Legislative Advocate with LLS, he helped convince state lawmakers to pass the much-needed Oral Chemotherapy Parity bill, by participating in lobbying efforts at the state house, writing stories for print and broadcast press, and conducted email and phone call campaigns to help educate lawmakers. He is also a champion for new legislation centered on Biosimilars clarification, Step Therapy and Specialty Tiers bills.

With the Rare Disease Legislative Advocacy (RDLA) and National Organization for Rare Disorders (NORD) he has appeared before several Congressional delegations; he helps educate Federal lawmakers about much-needed legislation to encourage more funding for biomedical research and effective, efficient & up-to-date healthcare policies.

For the past several years, Jack has been a fundraiser and volunteer spokesman on radio and TV with the Jimmy Fund and Boston Red Sox for the benefit of Dana Farber Cancer Institute (DFCI). He is featured in a national TV commercial about his treatment at DFCI. Jack is a former Co-chairman of DFCI's Patient Family Advisory Council (PFAC). He served on the Institute’s Patient Advisory Committee on the Epic EMR system upgrade program.

Described as "a one man band with a loud drum to engage and motivate others", with a busy 2016 calendar, you may find Jack speaking at advocacy, healthcare, medical education and Life Sciences professional events around the United States and Europe. Jack is a graduate of the University of Rhode Island and United States Navy veteran.

Julian Platon - MD, PhD - R&D and Medical Affairs Consultant, Switzerland

Dr. Med. Julian V. Platon

R&D and Medical Affairs Consultant, Switzerland


After his A Level in Bucharest he relocated to Germany in 1983 where he obtained the German Matura and studied Medicine in Cologne, London and Beer-Sheva. In parallel to his Conferral of Doctorate in Surgery he worked as a physician in the Department of Internal Medicine in Cologne, Germany.

Since 1994 Dr. Platon had different national and international, operational and executive medical positions in the Pharmaceutical, Medical Devices and Clinical Research Organization industry in Germany, USA and Switzerland. A special focus was addressed to Medical Affairs, Clinical Development & Operations and Pharmacovigilance (incl. QPPV). Stations of his professional life were Schwarz Pharma, Hoffmann-La Roche, Abbott, PharmaPart, Solvay and Alexion.

Dr. Platon is married, has three children and lives in Basel, Switzerland where he works as strategic and operational consultant in R & D and in Medical Affairs.

julian.platon@gmail.com

Laurentiu Micu - MD, PhD – Fundeni Hospital, Bucharest, Romania

Dr. Laurentiu Micu

Clinica de Medicina Interna, Institutul Clinic Fundeni, Bucuresti


Am absolvit Facultatea de Medicina Generala din cadrul Universitatii de Medicina si Farmacie Carol Davila Bucuresti in anul 1996.
In anul 2000 am obtinut titlul de medic specialist medicina generala, din 2005 - medic specialist medicina interna, iar din 2012 – medic primar medicina interna.
Angajat al Clinicii de Medicina Interna, Institutul Clinic Fundeni, din 2001 ca asistent cercetare stiintifica medicina interna, iar din 2007 ca cercetator stiintific.
In anul 2008 am obtinut titlul de Doctor in Medicina cu lucrarea: Factori predictivi ai raspunsului la tratamentul antiviral in infectiile cronice VHB si VHC (sub coordonarea Dlui Prof. Dr. Lucian Buligescu).
In prezent sunt membru al Subcomisiei de Hepatologie din Ministeul Sanatatii si Coordonator Secundar de Cercetare in Institutul Clinic Fundeni.
Din punct de vedere al activitatii stiintifice:
- peste 150 prezentari orale si sub forma de poster la simpozioane si congrese nationale si internationale - peste 40 articole publicate in reviste de specialitate;
- investigator principal sau subinvestigator in peste 25 studii clinice de faza II, III si IV';
- membru in Comitetul Executiv al Asociatiei Romane pentru Studiul Ficatului;
- membru al Asociatiei Romtransplant, al Societatii Romane de Gastroenterologie, Hepatolgie si Endoscopie Digestiva si al Societatii Romane de Medicina Interna;
- membru in comitetul de redactie al revistelor Journal of Translational Medicine and Research si The Lancet Oncology, editia romana.

Michael Oellerich - MD, PhD - Professor of Clinical Chemistry at the Medical Faculty, George-August-University Göttingen, Germany

Michael Oellerich

Professor of Clinical Chemistry at the Medical Faculty, George-August-University Göttingen, Germany


Michael Oellerich, MD, Hon MD, FACB, FAMM, FFPath (RCPI), FRCPath, is a chemical pathologist. Since 2012, he has an appointment as a Lower Saxony Distinguished Professor of Clinical Chemistry at the Department of Clinical Pharmacology, Medical Faculty (UMG) of the George-August-University Göttingen, Germany. He was chairman of the Department of Clincal Chemistry/Central Laboratory at UMG from 1991 to 2012. He received the Fellowship of the Royal College of Pathologists (FRCPath) in 2006, as well as the Fellowship of the National Academy of Clinical Biochemistry (FACB) of the American Association for Clinical Chemistry in 2012. Since 2013, he is a member of the Medical Advisory Board of Chronix Biomedical Inc., San Jose, CA, USA. From 1996 to 1998, he served as Dean of the Faculty of Medicine and as the deputy of the chief executive for research and teaching on the executive board for the Medical Center and Faculty of Medicine from 1999 to 2004. He was president of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) from 1997 to 1999, president of the German Association for Laboratory Medicine from 2001 to 2002, president of the German United Association for Clinical Chemistry and Laboratory Medicine (2003-2005), secretary-treasurer of the World Association of Societies of Pathology and Laboratory Medicine (WASPaLM) from 2005 to 2007, president of WASPaLM from 2009 to 2011, and immediate past-president of WASPaLM from 2011 to 2013. Since 2016, he is secretary of the International Society of Enzymology. Currently he is the Director Europe of WASPaLM and chair of the board of the Labs Are Vital consortium. From 1999 to 2010, he was a member of the Steering Committee of EUROLIFE, a network of European centers of excellence in life sciences. Since 2003, he is Editor-in-Chief of the journal Therapeutic Drug Monitoring. He was Associate Editor of Clinical Biochemistry (1996–2007), Associate Editor of Clinical Chemistry (2007-2013), and Guest Editor of Clinica Chimica Acta (special issue) in 2012. He was on the Editorial Board of Clinical Chemistry (2002-2007; 2014-2016), and currently is on the Editorial Boards of Clinical Biochemistry (2015-) as well as of J Mol Clin Pathol, Folia Med, Turk J Pediatr Biochem, and Indian J Clin Biochem. He is member of the Advisory Boards of Ital J Lab Med and Braz J Pathol Lab Med. His current research interests are in the field of therapeutic drug monitoring, with particular focus on endogenous biomarkers to achieve personalised immunosuppression in transplantation (e.g.graft-derived circulating cell-free DNA as “liquid biopsy”), as well as genotype-directed cancer care using cfDNA. Further topics include proteomics, and analytical techniques (e.g. LC-MS/MS). He has authored more than 400 publications (articles contributed to scientific journals, book chapters, books edited).

He served as External Examiner for the Second Professional Examination 2009/2010 of the Faculty of Medicine at the Chinese University of Hong Kong. He received the following awards: Ludolf-Krehl prize of the S.W. German Society for Internal Medicine in 1971, the IATDMCT Award, Cairns (Australia) 1999, the IATDMCT Charles Pippenger Award for Outstanding Contributions to Therapeutic Drug Monitoring, Washington (USA) 2001, the 2002 Canadian Society of Clinical Chemists Travelling Lectureship Award, the Professor-Landbeck-Award of the Society for Thrombosis and Hemostasis Research, Hamburg (Germany) 2004, the Perth PathCentre Visiting Lectureship, Western Australia 2004, the Honorary Fellowship of the Faculty of Pathology of the Royal College of Physicians of Ireland (FFPath RCPI), Dublin 2006, the Honorary Membership of the Romanian Society of Laboratory Medicine, Sibiu 2007, the WASPaLM Medal of Honor, Las Vegas (USA) 2011, the membership of the Bulgarian Academy of Sciences and Arts (BASA), Sofia 2012, the WASPaLM Gold Headed Cane, Quebec City (Canada) 2013, and the IATDMCT Honorary Membership, Salt Lake City (USA) 2013.

Tomasz Anyszek, MD, PhD - Synevo Poland and Synevo Central Lab Director

Dr. Tomasz Anyszek

Director of Synevo Central Lab since 2009 and Synevo Polska laboratory since 2014


Dr. Tomasz Anyszek is Director of Synevo Central Lab since 2009 and Synevo Polska laboratory since 2014.He is responsible for clinical trials operations in more than 40 laboratories in Central and Eastern Europe. Dr. Anyszek started his career with Virtual Central Laboratory, Netherlands in 2000 (Covance VCL since 2003) and his experience also includes the coordination of 16 regional Covance partner laboratories in Europe. During this period he performed 200 audits in clinical laboratories. Dr. Anyszek holds his PhD from Jagiellonian University, Poland. Prior to his business career, he taught clinical biochemistry and laboratory medicine at the Jagiellonian University medical faculty. Dr. Anyszek has authored more than 20 scientific publications and co-authored several books and monographies in the clinical chemistry and laboratory medicine area.

He is invited speakers for many conferences held in laboratory medicine and clinical research area.

Victoria Arama - INBI Matei Bals Bucharest, Romania

Dr. Victoria Arama

Sef de Sectie la Institutul National de Boli Infectioase Prof Dr Matei Bals Bucuresti,


Dr Victoria Arama este medic primar - Sef de Sectie la Institutul National de Boli Infectioase Prof Dr Matei Bals Bucuresti, avand titlul de Profesor universitar la UMF Carol Davila Bucuresti, Facultatea de Medicina, Disciplina de Boli Infectioase - Matei Bals.

Domeniile sale stiintifice de interes sunt reprezentate de: Infectiile virale (virusuri herpetice, virusuri hepatitice, infectia HIV/SIDA, virusuri gripale, papilomavirusuri); Terapia antivirala; Vaccinologia ; Rezistenta bacteriana la antibiotice; Infectiile in sarcina; Infectiile la imunodeprimati; Infectiile fungice si terapia antifungica.

In ceea ce priveste activitatea de cercetare stiintifica, Prof Dr Victoria Arama a fost coordonator stiintific sau membru in echipa de cercetare a numeroase granturi stiintifice castigate prin competitii nationale si internationale, precum si investigator principal in peste 40 de trialuri clinice internationale.

Din punct de vedere al activitatii stiintifice, Prof Dr Victoria Arama este autor a 4 monografii stiintifice si a peste 40 de capitole in alte monografii. Este membra a numeroase societati stiintifice nationale si internationale (ISID, ECCMID, EASL, GEEP, IHMF) si a publicat ca autor / coautor peste 500 lucrari stiintifice in reviste medicale din tara si strainatate.

Prof Dr Victoria Arama este membra in Comitetul Stiintific al revistei medicale franceze Medecine et Maladies Infectieuses si membra in Comitetul Editorial la alte 7 reviste medicale romanesti recunoscute.

Marius Geanta, MD - CEO Center for Innovation in Medicine, Romania

Marius Geanta, MD

CEO Center for Innovation in Medicine, Romania


Co-fondator al Centrului pentru Inovație în Medicină National Task Force Manager pentru România al Public Health Genomics Network Expert pe medicină personalizată al European Development Platform Membru al European Alliance of Personalized Medicine Participant în proiectul IT Future of Medicine Fondator și director general al companiei de comunicare specializată medicală Kol Medical Media Redactor-sef al revistei Hipocrate, brand de referință pentru comunitatea medicală din România

Iulia Chiriac - Secretar al Societății Române de Medicină Nucleară și Imagistică Moleculară

Iulia Chiriac

Secretar al Societății Române de Medicină Nucleară și Imagistică Moleculară


Am urmat cursurile de pregătire a Facultății de Medicină Generală din cadrul Universității de Medicină și Farmacie “Carol Davila” București între 2006-2012, iar din 2013 am început specializarea în Medicină Nucleară sub îndrumarea coordonatorilor de la Spitalul Universitar de Urgență Militar Central “Dr Carol Davila”. Din aprilie 2016 sunt angajată la Institutului Național de Endocrinologie “CI Parhon” București în Departamentul de Medicină Nucleară, Compartiment Cronici-Terapie Izotopică. În iunie 2015 am devenit secretar al Societății Române de Medicină Nucleară și Imagistică Moleculară. Din iulie 2015 am început să lucrez la proiectul “BIOMAT-ENDO: construcția bazei de date digitale pentru monitorizarea pacienților cu cancer tiroidian”. Acest proiect urmărește să digitalizeze informațiile cu ajutorul unui software tip "baza de date" , urmat de etapa pregătirii acestor date pentru analiza lor prin metode de statistica matematica. O parte din parametrii de interes sunt: zona geografică de proveniență a pacienților cu cancer tiroidian, vârsta actuală a pacienților, sexul, debutul bolii, factori genetici, tipul intervenției chirurgicale inițiale, dar și a reintervențiilor, rezultatul anatomo-patologic, doza totală terapeutică de 131I, valorile marker-ilor tumorali sau hematologici, precum și altele. Din punct de vedere al activității științifice sunt încă la început de drum, dar am participat cu lucrări la mai multe conferințe și congrese naționale și internaționale de profil.

00

zile


00

ore


00

minute


00

secunde


FORMULAR DE INREGISTRARE / TAXA PARTICIPARE SIMPOZION

INREGISTRARE INCHISA

Datorita cererii foarte mare, am ajuns la capacitatea maxima de inscrieri pentru acest eveniment.

Persoanele interesta sa participe, sunt rugate sa completeze formularul de mai jos, in care va rugam sa mentionati motivul pentru care doriti sa participati.

Dupa analizarea cererii dvs., va vom comunica raspunsul nostru.


TAXA PARTICIPARE SIMPOZION

1 Octombrie – 24 Noiembrie 2016, taxa este de 50 EURO per participant

25 Noiembrie 2016, taxa este de 100 EURO per participant

Termeni si conditii:
Prin trimiterea acestui formular, confirm că am citit şi acceptat
termenii şi conditiile detaliate mai jos.
Confirmare:
Pentru inscrierile gratuite, vom confirma participare dvs. in termen de 48 de ore dupa trimiterea formularului. In cazul in care nu primiti confirmarea, va rugam sa ne contactati la telefon sau trimiteti un email la: symposium@synevo.eu.
Pentru inscrierile cu taxa - Dupa trimiterea formularului completat, ve-ti primi factura proforma împreună cu detalii legate locaţia in care se va desfăşura evenimentul în termen de 48 ore dupa trimiterea formularului de înregistrare.
Daca in termen de 48 de ore nu primiti detaliile pentru plata taxei, va rugam sa ne contactati la telefon sau trimiteti un email la: symposium@synevo.eu.
Anularea înregistrarii:
In cazul cererii de anulare a înregistrarii facute cu o lună înainte de data începerii conferinţei, suma achitata reprezentand taxa de participare simpozion va fi rambursata, mai putin taxa de administrare de 50 %. Restituirea sumei se va face după terminarea simpozionului. In cazul cererii de anulare a înregistrarii facute cu mai putin de o lună înainte de data începerii conferinţei, suma achitata reprezentand taxa de participare simpozion nu se ramburseaza.
Cererea pentru schimbarea persoanei inscrise co o alta persona, poate fi facuta cu până la 3 zile înainte de inceperea simpozionului. Cererea de anulare a participarii va fi acceptata cel putin o lună înainte de eveniment şi trebuie facuta în scris.
Prin trimiterea acestui formular, confirm că am citit şi acceptat termenii si conditiile detaliate mai sus.

Furnizarea datelor sus-mentionate este obligatorie pentru incheierea acordului de participare la simpozion. Asadar, in cazul in care nu ne furnizati aceste date, nu veti putea participa la simpozion.

Prelucrarea acestor date este necesara pentru inscrierea la simpozion. Folosim CNP-ul dumneavoastra numai pentru confirmarea participarii dumneavoastra catre organizatiile care acorda credite profesionale.

Sunt de acord sa primesc informatii cu privire la activitatea SCLCT (simpozioane, cursuri, invitatii la evenimentele cu care avem legatura, potentiale colaborari ,campanii, activități promoționale,) prin:

E-mailTelefon

Sunt de acord cu prelucrarea imaginii mele in timpul simpozionului (poze)
DaNu

Synevo Central Lab Clinical Trials SRL este operator de date cu caracter personal. Prelucrarea datelor dumneavoastra este reglementata in Politica de Confidentialitate unde puteti gasi detalii despre temeiurile prelucrarilor, durata de prelucrare precum si in legatura cu drepturile dumneavoastra si modul in care acestea pot fi exercitate.

Puteți adresa orice întrebare în legătură cu prelucrarea datelor dumneavoastra catre Mihaela Mateas, Asistent Manager, Reprezentantul Societății, la adresa mihaela.mateas@synevo.eu

Plata înscrierii se va face către: Synevo Central Lab Clinical Trials Romania S.R.L., Str. Industriilor, nr. 25,Comuna Chiajna, judetul Ilfov. Cod fiscal: RO 30110226, J23/1113/2012, Cont bancar: RO62INGB0001008199978910 (RON), ING Bank-Sucursala Bucuresti.

LOCATIE

Hotel Intercontinental